Alemtuzumab and circulatory collapse Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5973418-3
Alemtuzumab side effect was reported by a Physician from GERMANY on Nov 21, 2008. Female patient, 69 years of age, was diagnosed with t-cell lymphoma, anxiety , hypertension and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: chills, circulatory collapse. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, NEUPOGEN, AMITRIPTYLINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #6038196-0
Alemtuzumab side effect was reported by a Physician from GERMANY on Jan 06, 2009. Female patient, 69 years of age, was diagnosed with t-cell lymphoma, anxiety , hypertension and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: circulatory collapse, pulmonary mycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, FILGRASTIM, AMITRIPTYLINE, HYDROCHLOROTHIAZIDE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #6119105-2
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 10, 2009. Female patient, 69 years of age, was diagnosed with t-cell lymphoma, anxiety , hypertension and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: circulatory collapse, pulmonary mycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, FILGRASTIM, AMITRIPTYLINE, HYDROCHLOROTHIAZIDE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.